OBJECTIVES: To test the hypothesis that MR imaging guided triamcinolone acetonide injection into the sacroiliac joints of children with enthesitis-related arthritis is feasible, accurate and safe; and effectively reduces sacroiliac inflammation and disease progression. METHODS: A retrospective analysis of 14 children (6/14 [43%] female, 8/14 (57%) male; mean age, 13.2 years; range, 6-16 years) who received MR imaging guided sacroiliac joint injections at 0.2 Tesla or 1.5 Tesla for enthesitis-related arthritis and acute sacroilitis refractory to medical therapy was performed. 20 mg triamcinolone acetonide were injected. Assessed were intra-articular drug delivery; image quality, duration, and complications. Success of therapy was defined by change of sacroiliac inflammation. Remission time and erosions were assessed by follow-up MRI (range, 10-22 months). RESULTS: Twenty four procedures resulted in intra-articular injection. Image quality was sufficient. No complications occurred. Procedure time was 40 min. Sedation time was 22 min. Success of therapy was achieved in 11/14 (79%) children. Sacroiliac inflammation decreased significantly (-59%). Median remission time was 13.7 months. No erosions occurred. CONCLUSIONS: MR imaging guided steroid injection of the sacroiliac joints is feasible, accurate, and safe and can effectively reduce sacroiliac inflammatory activity and may therefore aid in the prevention of disease progression.
OBJECTIVES: To test the hypothesis that MR imaging guided triamcinolone acetonide injection into the sacroiliac joints of children with enthesitis-related arthritis is feasible, accurate and safe; and effectively reduces sacroiliac inflammation and disease progression. METHODS: A retrospective analysis of 14 children (6/14 [43%] female, 8/14 (57%) male; mean age, 13.2 years; range, 6-16 years) who received MR imaging guided sacroiliac joint injections at 0.2 Tesla or 1.5 Tesla for enthesitis-related arthritis and acute sacroilitis refractory to medical therapy was performed. 20 mg triamcinolone acetonide were injected. Assessed were intra-articular drug delivery; image quality, duration, and complications. Success of therapy was defined by change of sacroiliac inflammation. Remission time and erosions were assessed by follow-up MRI (range, 10-22 months). RESULTS: Twenty four procedures resulted in intra-articular injection. Image quality was sufficient. No complications occurred. Procedure time was 40 min. Sedation time was 22 min. Success of therapy was achieved in 11/14 (79%) children. Sacroiliac inflammation decreased significantly (-59%). Median remission time was 13.7 months. No erosions occurred. CONCLUSIONS: MR imaging guided steroid injection of the sacroiliac joints is feasible, accurate, and safe and can effectively reduce sacroiliac inflammatory activity and may therefore aid in the prevention of disease progression.
Authors: J S Lewin; C A Petersilge; S F Hatem; J L Duerk; G Lenz; M E Clampitt; M L Williams; K R Kaczynski; C F Lanzieri; A L Wise; J R Haaga Journal: AJR Am J Roentgenol Date: 1998-06 Impact factor: 3.959
Authors: Jan Fritz; Thomas Niemeyer; Stephan Clasen; Jakub Wiskirchen; Gunnar Tepe; Bruno Kastler; Thomas Nägele; Claudius W König; Claus D Claussen; Philippe L Pereira Journal: Radiographics Date: 2007 Nov-Dec Impact factor: 5.333
Authors: F Streitparth; T Walter; U Wonneberger; S Chopra; F Wichlas; M Wagner; K G Hermann; B Hamm; U Teichgräber Journal: Eur Radiol Date: 2009-09-02 Impact factor: 5.315
Authors: Philipp Bosch; Francesco Carubbi; Carlo Alberto Scirè; Xenofon Baraliakos; Louise Falzon; Christian Dejaco; Pedro M Machado Journal: RMD Open Date: 2021-11